Trupanion's (TRUP) "Hold (C-)" Rating Reaffirmed at Weiss Ratings

Key Points

• Trupanion's stock rating was reaffirmed as "hold (C-)" by Weiss Ratings, with a consensus target price of $53.80.
• The company's recent quarterly earnings showed a notable improvement, reporting $0.22 EPS, surpassing estimates and marking a 12.3% year-over-year revenue increase.
• Insider transactions included the CEO selling nearly 9,000 shares and significant stake increases from institutional investors like Wellington Management, reflecting continued interest in the company's performance.

Trupanion (NASDAQ:TRUP - Get Free Report)'s stock had its "hold (c-)" rating reissued by investment analysts at Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

TRUP has been the subject of several other research reports. Stifel Nicolaus boosted their price objective on Trupanion from $41.00 to $45.00 and gave the company a "hold" rating in a report on Friday, August 8th. Piper Sandler lifted their price target on Trupanion from $62.00 to $67.00 and gave the company an "overweight" rating in a research note on Friday, August 8th. Finally, Cantor Fitzgerald upgraded Trupanion to a "hold" rating in a research note on Wednesday, August 13th. Two research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $53.80.

Trupanion Stock Performance

Shares of TRUP stock traded up $0.02 on Wednesday, hitting $42.32. The company had a trading volume of 287,845 shares, compared to its average volume of 419,566. The firm has a market cap of $1.82 billion, a P/E ratio of 162.78 and a beta of 1.83. The company has a 50-day moving average price of $45.61 and a 200-day moving average price of $45.33. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.32. Trupanion has a twelve month low of $31.00 and a twelve month high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The financial services provider reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.25. The business had revenue of $353.56 million during the quarter, compared to analysts' expectations of $346.73 million. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The company's revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.14) EPS. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities research analysts predict that Trupanion will post 0.13 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Trupanion news, CEO Margaret Tooth sold 8,961 shares of the business's stock in a transaction that occurred on Thursday, September 25th. The stock was sold at an average price of $41.88, for a total transaction of $375,286.68. Following the completion of the sale, the chief executive officer directly owned 144,229 shares in the company, valued at approximately $6,040,310.52. The trade was a 5.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 2,800 shares of the business's stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $45.56, for a total value of $127,568.00. Following the sale, the chief financial officer owned 6,451 shares of the company's stock, valued at approximately $293,907.56. This trade represents a 30.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 61,761 shares of company stock worth $2,739,621. Corporate insiders own 5.42% of the company's stock.

Institutional Investors Weigh In On Trupanion

Several large investors have recently bought and sold shares of the company. Wellington Management Group LLP increased its stake in Trupanion by 13.2% during the 1st quarter. Wellington Management Group LLP now owns 2,491,227 shares of the financial services provider's stock worth $92,848,000 after buying an additional 290,788 shares in the last quarter. State Street Corp grew its position in shares of Trupanion by 2.6% in the second quarter. State Street Corp now owns 1,285,419 shares of the financial services provider's stock valued at $71,148,000 after purchasing an additional 32,839 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Trupanion by 7.0% in the second quarter. Geode Capital Management LLC now owns 860,988 shares of the financial services provider's stock valued at $47,662,000 after purchasing an additional 56,671 shares in the last quarter. Balyasny Asset Management L.P. grew its position in shares of Trupanion by 8.1% in the second quarter. Balyasny Asset Management L.P. now owns 449,106 shares of the financial services provider's stock valued at $24,858,000 after purchasing an additional 33,650 shares in the last quarter. Finally, Hosking Partners LLP grew its position in shares of Trupanion by 86.9% in the first quarter. Hosking Partners LLP now owns 397,656 shares of the financial services provider's stock valued at $14,821,000 after purchasing an additional 184,936 shares in the last quarter.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.